Rev and Translation of Cytoplasmic HIV-1 Rnas - Salvatore Arrigo

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of Allergy and Infectious Diseases (NIAID)
Type: First Independent Research Support & Transition (FIRST) Awards (R29)
Project #: 5R29AI032415-05
Application #: 2067298
Study Section: AIDS and Related Research Study Section 3 (ARRC)

Project Start: 1992-07-01
Project End: 1997-04-30
Budget Start: 1996-05-01
Budget End: 1997-04-30
Support Year: 5
Fiscal Year: 1996
Total Cost
Indirect Cost

Institution

Name: Medical University of South Carolina
Department: Microbiology/Immun/Virology
Type: Schools of Medicine
DUNS #: 183710748

City: Charleston
State: SC
Country: United States
Zip Code: 29425

Related projects


NIH 1996 R29 AI	Rev and Translation of Cytoplasmic HIV-1 Rnas Arrigo, Salvatore J. / Medical University of South Carolina
NIH 1995 R29 AI	Rev and Translation of Cytoplasmic HIV-1 Rnas Arrigo, Salvatore J. / Medical University of South Carolina
NIH 1994 R29 AI	Rev and Translation of Cytoplasmic HIV-1 Rnas Arrigo, Salvatore J. / Medical University of South Carolina
NIH 1993 R29 AI	Role of Rev in Translation of Cytoplasmic HIV-1 Rnas Arrigo, Salvatore J. / Medical University of South Carolina
NIH 1992 R29 AI	Role of Rev in Translation of Cytoplasmic HIV-1 Rnas Arrigo, Salvatore J. / Medical University of South Carolina

Publications

Campbell, L H; Borg, K T; Haines, J K et al. (1994) Human immunodeficiency virus type 1 Rev is required in vivo for binding of poly(A)-binding protein to Rev-dependent RNAs. J Virol 68:5433-8

Comments

Be the first to comment on Salvatore Arrigo's grant